1 | How can less invasive interventions be performed for CHD with the same outcomes as open-heart surgery? |
2 | How can the longevity of the Fontan circulation be prolonged and the impact of complications (eg, liver, protein-losing enteropathy, renal, endocrine, fertility) be reduced? |
3 | What is the impact of living with CHD on mental health in adults and how can this be improved through access to psychological support and other therapies? |
4 | How can technology be used to deliver personalised care and improve outcomes of those with CHD (eg, artificial intelligence, 3D printing, genomics, stem cells, organ regeneration)? |
5 | What are the risks and limitations associated with pregnancy, childbirth and motherhood for women with CHD, and what information and support is available? |
6 | What are the best treatment strategies for heart failure in adults with CHD, in particular those with a systemic right ventricle? |
7 | How can the management of arrhythmias, including sudden cardiac death, in adults with CHD be improved? |
8 | How can the indications, timing of referral and outcomes of transplantation and long-term mechanical support in adults with CHD be improved? |
9 | What is the impact of living with CHD on quality of life in adults and how can this be improved? |
10 | How can the frequency or need for reoperations be reduced for people with CHD (eg, improved valve/conduit longevity or that grow with the patient)? |